Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pincus

Showing results (101-110 of 216) with videos related to

Pageof 22
Sort By:
Biochemical and Biophysical Research Communications|December 15, 1988
The structure of the amino terminal transforming segment of the p21 protein, Tyr4-Thr20 (with Asp12), by two-dimensional NMRP A Longo, M S Broido, J Chen, et al.
Journal of Protein Chemistry|June 6, 2000
Molecular dynamics analysis of the structures of ras-guanine nucleotide exchange protein (SOS) bound to wild-type and oncogenic ras-p21. Identification of effector domains of SOSJ M Chen, F K Friedman, M J Hyde, et al.
The Journal of Biological Chemistry|September 20, 1996
Activation of c-Jun-NH2-kinase by UV irradiation is dependent on p21rasV Adler, M R Pincus, A Polotskaya, et al.
Current Pharmaceutical Design|July 7, 2011
Anti-cancer peptides from ras-p21 and p53 proteinsMatthew R Pincus, Maly Fenelus, Ehsan Sarafraz-Yazdi, et al.
American Journal of Otolaryngology|May 1, 1996
Focal myositis of the sternocleidomastoid muscle: a case report and review of the literatureG D Josephson, H de Blasi, S McCormick, et al.
Biomedicines|February 25, 2023
Peptides That Block RAS-p21 Protein-Induced Cell TransformationMatthew R Pincus, Bo Lin, Purvi Patel, et al.
Journal of Protein Chemistry|March 10, 2001
Identification, using molecular dynamics, of an effector domain of the ras-binding domain of the raf-p74 protein that is uniquely involved in oncogenic ras-p21 signalingJ M Chen, K Rijhwani, F K Friedman, et al.
FEBS Letters|June 13, 1994
Specificity of the cytochrome P-450 interaction with cytochrome b5Y Omata, R C Robinson, H V Gelboin, et al.
Cancer Therapy|November 17, 2007
Novel peptides from the RAS-p21 and p53 proteins for the treatment of cancerWilbur B Bowne, Josef Michl, Martin H Bluth, et al.
The Journal of Laboratory and Clinical Medicine|October 1, 1990
Octapeptide segments from the amino terminus of glycophorin A contain the antigenic determinants of the M and N blood groups systemsJ T Pedersen, H Kaplan, L Wedeck, et al.
Pageof 22

Showing results (101-110 of 216) with videos related to

Sort By:
Pageof 22
Biochemical and Biophysical Research Communications|December 15, 1988
The structure of the amino terminal transforming segment of the p21 protein, Tyr4-Thr20 (with Asp12), by two-dimensional NMRP A Longo, M S Broido, J Chen, et al.
Journal of Protein Chemistry|June 6, 2000
Molecular dynamics analysis of the structures of ras-guanine nucleotide exchange protein (SOS) bound to wild-type and oncogenic ras-p21. Identification of effector domains of SOSJ M Chen, F K Friedman, M J Hyde, et al.
The Journal of Biological Chemistry|September 20, 1996
Activation of c-Jun-NH2-kinase by UV irradiation is dependent on p21rasV Adler, M R Pincus, A Polotskaya, et al.
Current Pharmaceutical Design|July 7, 2011
Anti-cancer peptides from ras-p21 and p53 proteinsMatthew R Pincus, Maly Fenelus, Ehsan Sarafraz-Yazdi, et al.
American Journal of Otolaryngology|May 1, 1996
Focal myositis of the sternocleidomastoid muscle: a case report and review of the literatureG D Josephson, H de Blasi, S McCormick, et al.
Biomedicines|February 25, 2023
Peptides That Block RAS-p21 Protein-Induced Cell TransformationMatthew R Pincus, Bo Lin, Purvi Patel, et al.
Journal of Protein Chemistry|March 10, 2001
Identification, using molecular dynamics, of an effector domain of the ras-binding domain of the raf-p74 protein that is uniquely involved in oncogenic ras-p21 signalingJ M Chen, K Rijhwani, F K Friedman, et al.
FEBS Letters|June 13, 1994
Specificity of the cytochrome P-450 interaction with cytochrome b5Y Omata, R C Robinson, H V Gelboin, et al.
Cancer Therapy|November 17, 2007
Novel peptides from the RAS-p21 and p53 proteins for the treatment of cancerWilbur B Bowne, Josef Michl, Martin H Bluth, et al.
The Journal of Laboratory and Clinical Medicine|October 1, 1990
Octapeptide segments from the amino terminus of glycophorin A contain the antigenic determinants of the M and N blood groups systemsJ T Pedersen, H Kaplan, L Wedeck, et al.
Pageof 22